sglt2 inhibitors with glp 1 vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain Renal outcomes of SGLT2 inhibitors

Quercetin demonstrated an increase in the RMSD till 50ns beyond which it suddenly peaked its value at 60 ns beyond which it stabilizes throughout the simulation with an average RMSD value of 0.31 nm (Fig

P.Dallinga-ThieG

10.1016/j.bbamcr.2019.118535 Biochim

About this article Cite this article Siddiqi, A.K., Khan, M.S., Kulkarni, A

Wheat proteins: a valuable resource to improve nutritional value of bread

This review integrates mechanistic insights with translational advances, outlining how dysregulation of chaperones, autophagy-mitophagy, the ubiquitinproteasome system, and ER stress pathways drive human diseases, while highlighting emerging therapeutic platforms, from pharmacological chaperones and autophagy modulators to targeted protein degradation technologies, CRISPR screens, spatial biology, and AI-guided drug discovery